INTERPHEX Launches Online Resource for Pharma, Bio, and Device Content
The platform provides access to case studies, new technologies, expert insight, published and peer-reviewed articles, webinars, news updates, videos, and interviews.
INTERPHEX announced on April 23, 2020 that it is launching RECONNEX 365, a year-round online resource for pharma, bio, and device development and manufacturing content and information.
The platform provides access to case studies, new technologies, expert insight, published and peer-reviewed articles, webinars, news updates, videos, and interviews, according to a company press release. Exhibitors at INTERPHEX on April 20–22, 2021 at the Javits Center in New York, NY will have the ability to digitally introduce new and existing technical content, technologies, and solutions, while attendees will be able to schedule onsite meetings to experience the products, technologies, and services.
"Our new online resource reimagines procurement strategies and enables one to stay connected to the industry and leading suppliers year-round, setting companies with procurement needs up for future success," said Kate Scott, event director, INTERPHEX, in the press release. "Leading suppliers continue to select INTERPHEX to feature their innovative technologies, products, and services designed to reduce cost, increase productivity, and maximize efficiency."
Source: INTERPHEX
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
